# FDA Inspection 1067678 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - August 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/3c041f5a-2a6c-4c99-8b5b-11e9ce5a735c
Source feed: FDA_Inspections

> FDA Inspection 1067678 for Qilu Antibiotics Pharmaceutical Co. , Ltd. on August 16, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067678
- Company Name: Qilu Antibiotics Pharmaceutical Co. , Ltd.
- Inspection Date: 2018-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1210065 - 2023-05-30](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/8aa0dc2a-11f5-467c-8d7a-3d6b0a405998)
- [FDA Inspection 945452 - 2015-09-22](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/f29ad899-c3c5-4019-a20c-62e964543a4f)
- [FDA Inspection 851836 - 2013-09-20](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/262e239b-0a36-41ec-bca3-2a6be88e988d)

Company: https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c